Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2356 (LINC02356) is a human gene that encodes a long intergenic non-protein coding RNA, classified as a lincRNA, which by definition refers to non-protein coding RNA transcripts greater than 200 nucleotides in length and located between protein-coding genes[1][3]. LINC02356 currently lacks well-characterized biological functions, disease associations, or defined roles as a therapeutic target in the literature or gene databases[1]. Generally, lincRNAs can regulate chromatin organization, RNA stability, and gene transcription, often acting as fine-tuners of gene expression and sometimes displaying tissue-specific functions[3]. However, no specific biological activities, disease implications, or interacting compounds are established for LINC02356.\n\nContext and supporting details:\n- The gene is listed in genomic databases as a distinct lincRNA, with no protein product and no overlap with coding genes[1].\n- The broader lincRNA family participates in multiple regulatory processes, such as chromatin remodeling and acting in *cis* or *trans* to control gene expression, but most lincRNAs (including LINC02356) remain functionally uncharacterized at present[3].\n- There is no evidence LINC02356 is a pharmacological 'target' (e.g., not a receptor, enzyme, transporter, etc.), nor is there evidence it interacts with any drugs or is implicated in diseases in a clinically meaningful way at this time[1][3].\n- No common alternative symbols or aliases besides "LINC02356" are reported[1].\n\nIf more details about specific biological functions or associations become available in future literature, these entries could be updated accordingly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2356 (LINC02356).